Amedisys (NASDAQ:AMED) said that second quarter net income will be approximately $1.12 per share. These results include nonrecurring costs of 17 cents per share primarily associated with realignment of operations, and the Senate Finance Committee and SEC investigations; $3.5 million or 7 cents per share they received from CMS under their pay for performance demonstration program and a reversal of the first quarter corporate bonus accrual which amounted to 7 cents per share. The net effect of these items on reported earnings per share was a reduction of approximately 3 cents per share.
RBC Capital Markets (NYSE:RY) downgraded Amedisys from outperform to sector perform and shares are down about 23.5%.
CommVault (NASDAQ:CVLT) said that based on preliminary results that have not yet been reviewed by its auditors, the company expects to report revenue for the first quarter of approximately $66.3 million. This would represent a decrease of 10% compared with revenue in the fourth fiscal quarter of 2010.
Non-GAAP income from operations for the first quarter of fiscal 2011 is expected to be approximately $7.6 million, a decrease of 19% compared to the same period of the prior year. The Company expects Non-GAAP net income for the first quarter of fiscal 2011 to be approximately $5.1 million, a decrease of 21% compared to the same period of the prior year.
shares of CommVault are down about 20%.
JP Morgan (NYSE:JPM) downgraded shares of ATP Oil & Gas (ATPG) to underweight from netural and assigned a $10 price target. Shares of ATP are down 6.5%.
BioMimetic Therapeutics (BMTI) announced today a public offering of 5 million shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.